Is erlotinib available in China?

Erlotinib has been launched in China and has been included in medical insurance. Patients can purchase it domestically. The domestic price ranges from about 700 to 1,000. The specification is 150mg*7 tablets. Due to different medical insurance policies in different places, the price is also different. Please consult the local pharmacy or medical insurance bureau for details. Erlotinib abroad is mainly an Indian generic drug, with a price of about 900 yuan. The specifications are divided into 100mg*30 tablets and 150mg*30 tablets, which are about four times the domestic specifications, but the price is similar to that in China. Erlotinib inhibits the activity of EGFR (epidermal growth factor receptor) kinase and interferes with intracellular signaling pathways, thereby slowing down the growth, differentiation and spread of tumor cells. In some patients with non-small cell lung cancer, EGFR gene mutations lead to continued activation of the receptor and promote abnormal proliferation of cancer cells. Erlotinib works by targeting this abnormal cell signaling pathway to inhibit cancer development.